Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0, a site version/UI change that does not modify study details.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor metadata update with no visible changes to the study details.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Primary peritoneal carcinoma and Fallopian tube cancer to the study's Conditions, and updated the page version from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check65 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-facing content changes were observed.SummaryDifference0.1%

- Check72 days agoChange DetectedGlossary display has been added, and a new 'Last Update Submitted that Met QC Criteria' indicator appears, along with a 'No FEAR Act Data' notice and a revision banner for v3.4.0. The previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' information has been removed.SummaryDifference0.2%

- Check87 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; no changes to study details or content.SummaryDifference0.1%

Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.